Offer - Urjas Oil for just ₹ 1 X
Prexaron 4 ml Injection, a prescription drug, is manufactured in various forms such as Injection. Primarily, it is used for the treatment of Stroke. The alternative uses of Prexaron 4 ml Injection have also been explained below.
Medical history of the patient along with age and gender determines the dosage of Prexaron 4 ml Injection. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
The most common side effects of Prexaron 4 ml Injection are Headache, Blurred vision, Increased blood pressure. Besides the aforementioned side effects, there are other adverse effects of Prexaron 4 ml Injection as well, which are listed below. Such side effects of Prexaron 4 ml Injection normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Prexaron 4 ml Injection's effect during pregnancy is Unknown and Unknown while nursing. Further, the section on Prexaron 4 ml Injection related warnings talks about Prexaron 4 ml Injection's effects on the liver, heart and kidney.
Other contraindications of Prexaron 4 ml Injection have been discussed in the sections ahead.
Besides this, Prexaron 4 ml Injection may also have severe interaction with some medicines. See below for a complete list.
In addition to the above precautions for Prexaron 4 ml Injection, it is important to know that it is not safe while driving, and is not habit-forming.
Prexaron 4 ml Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Prexaron 4 ml Injection safe for pregnant women?
No research has not been done till date on the safety of Prexaron for pregnant women. So its effects on pregnant women are unknown.
Is the use of Prexaron 4 ml Injection safe during breastfeeding?
No research work has been carried out till date on effect of Prexaron on breastfeeding women. So it is not known whether taking Prexaron will cause side effects or not.
What is the effect of Prexaron 4 ml Injection on the Kidneys?
In the absence of any research, there are no known side effects of Prexaron on kidneys.
What is the effect of Prexaron 4 ml Injection on the Liver?
Side effects of Prexaron on the liver are unknown because research on this has not been conducted yet.
What is the effect of Prexaron 4 ml Injection on the Heart?
There is no research available on the side effects of Prexaron on the heart. Therefore, its impact is unknown.
If you are suffering from any of the following diseases, you should not take Prexaron 4 ml Injection unless your doctor advises you to do so -
Is this Prexaron 4 ml Injection habit forming or addictive?
No, there is no any evidence that Prexaron 4 ml Injection is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Prexaron 4 ml Injection as you may feel sleepy.
Is it safe?
Prexaron 4 ml Injection is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
Yes, taking Prexaron 4 ml Injection can treat mental disorders.
Interaction between Food and Prexaron 4 ml Injection
It is safe to take Prexaron 4 ml Injection with food.
Interaction between Alcohol and Prexaron 4 ml Injection
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Prexaron 4 ml Injection.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 491